Lisa Rojkjaer - Chief Medical Officer at Viracta Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
VIRX
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Lisa Rojkjaer since 13 Aug 2025

Reported holdings for Lisa Rojkjaer in Viracta Therapeutics, Inc.

Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
37,146
Estimated value
$53,862
Report date
25 Feb 2023
Price
$1.45
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Common Stock
Shares / value
48,087
Estimated value
$23,717
Report date
27 Feb 2023
Price
$0.4932
Ownership
Direct
Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
150,000
Estimated value
Report date
16 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Lisa Rojkjaer in Viracta Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .